Biology subjects

Duda, G. N.

Publications and source records attributed to Duda, G. N..

11 recordsLinked to original sources

bioRxiv2026

Patterned alginate hydrogel spatially guides collagen fibrillogenesis, viscoelasticity and endothelial cell invasion

Angiogenesis following injury has been shown to be driven by fibrillar proteins of the extracellular matrix (ECM), such as collagen. However, the use of protein-based biomaterials presents some challenges, such as uncontrolled degradation and limited tuneability. We demonstrate how to create patterned interpenetrating networks (IPNs) based on covalently crosslinked alginate and physically crosslinked collagen that provide suitable mechanical properties to support migration of endothelial cells (ECs) in a spatially controlled manner. Low molecular weight alginate is functionalized with norbornene (N) or tetrazine (T), which enables two independent covalent crosslinking methods: UV-mediated and degradable crosslinks with matrix metalloproteinase (MMP) sensitive peptides (Deg) and slower spontaneous N:T non-degradable crosslinks (noDeg). Using photolithography, patterns in degradation, collagen fibrillogenesis, microarchitecture and matrix viscoelasticity are created. The potential of such 3D patterned alginate-collagen (Alg-Col) IPNs to spatially guide EC invasion and proliferation was tested in a microfluidics platform resembling an early healing setting. Only regions combining collagen fibrillogenesis, alginate degradability and viscoelasticity demonstrated EC cell invasion similar to the ones found in vivo following injury. The 3D patterned Alg-Col IPNs are compatible with microfluidics, offer an strategy to widen the applications of protein-based hydrogels and present a versatile platform for tissue engineering and disease modeling.

bioengineering↗

bioRxiv2025

Distinct matrix viscoelasticity in bone fracture hematoma steers macrophage polarization

Physical properties of the extracellular matrix (ECM) are key regulators of cellular behavior. Following injury, the formation of a hematoma establishes a provisional niche that initiates and regulates healing responses. However, the influence of hematoma viscoelastic properties on immune cell behavior remains poorly understood. Here, we show that distinct ECM viscoelastic properties of the maturing fracture hematoma steer macrophage polarization from pro-inflammatory to pro-regenerative characteristics. Tissue analyses of ex vivo human samples revealed that hematoma viscoelastic properties change with ECM remodeling during healing progression, with the late-phase stress relaxation time constant, {tau}2, increasing significantly with days post-injury. Using alginate hydrogels in 3D culture, we engineered extracellular microenvironments with tunable {tau}2 but constant stiffness to study their role in macrophage polarization. Our data demonstrate that ECM {tau}2 properties guide macrophage phenotype, characterized by high {tau}2 promoting pro-inflammatory activation, while low {tau}2 supported anti-inflammatory phenotypes. This regulation of macrophage polarization by ECM stress relaxation properties persists even under toll-like receptor-coactivation. Single-cell RNA sequencing revealed distinct transcriptional programs associated with different ECM {tau}2 values, with many of the differentially expressed genes related to metabolic processes. The transcriptomic profiles of macrophages primed by different ECM {tau}2 aligned with in vivo healing trajectories, with the gene signature score of the low ECM {tau}2 decreasing over time. Our findings uncover the immune-regulatory function of specific hematoma stress relaxation properties associated with healing progress after injury, and suggest {tau}2 as potential mechanobiological target to be leveraged in novel biomaterials-based regenerative therapies.

bioengineering↗

bioRxiv2025

The cortical microenvironment drives early immune organization and controls early osteoclastogenesis in bone healing

Bone regeneration is a complex, tightly-regulated process involving coordinated interactions of immune and stromal cells. Early phases of healing rely on the timely clearance of debris, a task primarily carried out by macrophages and osteoclasts. However, the sequence of events leading to the presence of osteoclasts at the fracture site and how this is shaped by local tissue microenvironments remains poorly understood, particularly at single-cell and spatial resolution. Using single-cell RNA sequencing and multi-epitope ligand cartography, we mapped the spatial organization of distinct cell compartments engaged in early fracture healing in both young and aged mice at the start of healing. Surprisingly, we found that young mice exhibited an increased presence of activated osteoclasts at day 7, concentrated within the cortical niche. This compartment was also characterized by a spatially restricted immune response with a selective accumulation of distinct macrophage types jointly interacting with neutrophils and stromal cells. This raised the possibility that local cell organization influences osteoclast precursor differentiation. We identified a distinct Spp1hi macrophage subset restricted to the cortex, which acted as a transitional precursor population giving rise to osteoclasts. Neutrophils preceded this Spp1hi macrophage accumulation and may promote their recruitment through chemotactic signaling. This coordination was less pronounced in aged mice despite preserved transcriptional states. In parallel, stromal cells in young animals displayed higher expression of essential niche factors further supporting local osteoclastogenesis at the cortex. Together, our findings identify distinct macrophage precursors and reveal early, cortex-specific niche activity supporting osteoclastogenesis. This provides a new framework for understanding the initiation of spatial immune-stromal interactions for the early stages of regeneration.

immunology↗

bioRxiv2025

Osmotic niche changes as multifaceted trigger of cellular regenerative processes in organ injury

Cell niches are organ-specific and characterized by a variety of distinct biophysical cues, including mechanics and osmolality. Injury disrupts this cellular environment and marks the start of regenerative processes. It remains unclear whether bone fracture alters the osmolality of bone marrow, and how associated changes in the extracellular matrix (ECM) affect marrow-resident cells in the onset of regeneration. Here we present analyses of human tissue samples indicating that osmolality differences among tissue types lead to a sudden drop in bone marrow osmolality upon fracture, which in turn enhances ECM viscoelasticity. We reveal that a sudden osmolality drop, mimicked in vitro by lowering ion concentrations, triggers bone regenerative processes in mesenchymal stromal cells (MSCs), markedly enhancing their spreading, proliferation, and osteogenic differentiation while residing in osmolality- responsive viscoelastic ECM. Conversely, in non-physiologically elastic ECM, similarly increased osmolality augments MSC osteogenic differentiation, suggesting that ECM viscous dissipation redirects cellular responses to osmotic changes. Mechanistically, the regenerative function of the osmolality drop depends on the matrix providing cell-adhesion ligands and physiological viscoelastic properties. Sequencing data show altered gene expression already two hours after differentiation start, with distinct characteristics related to chromatin structural changes specifically associated with hypoosmolality. Our results suggest that the osmolality drop serves as fast-acting regenerative stimulus for MSCs by extracellularly enhancing matrix viscoelasticity, while altering chromatin structure intracellularly. This stimulus upon injury potentially orchestrates the individual responses of multiple cell types within a niche, facilitating a collective action towards regeneration. Learning how to leverage osmotic cues to induce regenerative cascades may eventually advance local and personalized therapeutic strategies for patients with impaired healing capacity. We anticipate that the integration of osmotic and mechanical ECM properties, as demonstrated in our assay, will catalyze advanced 3D cell culture systems and offer new perspectives on material design in tissue engineering, disease modeling, and mechanobiology.

bioengineering↗

bioRxiv2024

3D patterns in alginate hydrogel degradation spatially guide YAP nuclear translocation and hMSC osteogenic differentiation

Tissue engineering involves assembling cells and mimicking the complex anisotropic architecture of biological tissues to perform specific functions. This study explores the impact of patterned hydrogels with anisotropic degradation compared to single-phase materials on the potential of enhancing cell spreading, collective alignment, mechanotransduction and osteogenic differentiation of encapsulated human mesenchymal stromal cells (hMSCs). Spatial patterns of degradable (Deg) and non-degradable (noDeg) subregions are formed by photolithography: UV-triggered thiol-ene crosslinking with matrix metalloprotease (MMP) sensitive peptides form Deg phases, while non-UV exposed regions result in Diels-Alder spontaneous click crosslinking and noDeg phases. 3D patterns in hydrogel degradation enhance hMSC spreading and allow collective cell alignment in Deg areas, while cells remain rounded with no alignment in noDeg regions. In addition, we observe a boosted osteogenic differentiation when compared to single-phase materials, as mid osteogenic markers (osteocalcin) are expressed at day 14 in anisotropic gels, whereas in single-phase only early osteogenic markers are found (osterix). Mechanosensing pathways were evaluated using the expression and localization of YAP. Deg sections in patterned materials have an enhanced nuclear translocation and higher YAP expression compared to single-phase Deg materials and noDeg sections. This effect is lost and no patterns in YAP expression and localization emerge when using an MMP-scramble peptide or no-RGD materials. These findings demonstrate that 3D patterns in alginate hydrogel degradation guide hMSC spreading, collective alignment, enhance YAP nuclear translocation and osteogenic differentiation. Mimicking tissue anisotropy in 3D patterned hydrogels could have broad applications in biofabrication and tissue engineering. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=79 SRC="FIGDIR/small/588803v3_ufig1.gif" ALT="Figure 1"> View larger version (34K): org.highwire.dtl.DTLVardef@f7aa3aorg.highwire.dtl.DTLVardef@1c8d2a4org.highwire.dtl.DTLVardef@17d2371org.highwire.dtl.DTLVardef@a1d6a2_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical AbstractC_FLOATNO C_FIG

bioengineering↗

bioRxiv2023

Aging impairs muscle regeneration by desynchronizing matrix mechano-signaling and macrophage immunomodulation via fibro-adipogenic progenitors

Skeletal muscle regeneration depends on the function of fibro/adipogenic progenitors (FAPs). Here we show that aging impairs myogenic stem cells by disrupting the integration of extracellular matrix and immunomodulatory functions within the stem cell niche, thereby promoting fibro/fatty degeneration. We identify the FAP-secreted protein Periostin as a niche factor that is decreased in aged muscle and in circulation of aged humans with low-exercise lifestyle. Periostin controls FAP-expansion after injury and its depletion fate-regulates FAPs towards adipogenesis. This leads to delayed pro- to anti-inflammatory macrophage transition during regeneration. Transplantation of young FAPs with high Periostin secretion, but not Periostin-deficient FAPs, into aged muscle restores inflammation resolution and successful regeneration. Mechanistically, Periostin activates Focal adhesion kinase- and AKT-signaling in macrophages via integrins to promote an anti-inflammatory profile, which synchronizes matrix-derived mechanosensory signaling and immunomodulation. These results uncover a novel role of FAP-based regulation that orchestrates successful muscle regeneration and prevents fibro/fatty degeneration.

physiology↗

bioRxiv2023

Hydrogels with stiffness-degradation spatial patterns control anisotropic 3D cell response

In nature, tissues are patterned, but most biomaterials used in human applications are not. Patterned biomaterials offer the opportunity to mimic spatially segregating biophysical and biochemical properties found in nature. Engineering such properties allows to study cell-matrix interactions in anisotropic matrices in great detail. Here, we developed alginate-based hydrogels with patterns in stiffness and degradation, composed of distinct areas of soft non-degradable (Soft-NoDeg) and stiff degradable (Stiff-Deg) material properties. The hydrogels exhibit emerging patterns in stiffness and degradability over time, taking advantage of dual Diels-Alder covalent crosslinking and UV-mediated peptide crosslinking. The materials were mechanically characterized using rheology for single-phase and surface micro-indentation for patterned materials. 3D encapsulated mouse embryonic fibroblasts (MEFs) allowed to characterize the anisotropic cell-matrix interaction in terms of cell morphology by employing a novel image-based quantification tool. Live/dead staining showed no differences in cell viability but distinct patterns in proliferation, with higher cell number in Stiff-Deg materials at day 14. Patterns of projected cell area became visible already at day 1, with larger values in Soft-NoDeg materials. This was inverted at day 14, when larger projected cell areas were identified in Stiff-Deg. This shift was accompanied by a significant decrease in cell circularity in Stiff-Deg. The control of anisotropic cell morphology by the material patterns was also confirmed by a significant increase in filopodia number and length in Stiff-Deg materials. The novel image-based quantification tool was useful to spatially visualize and quantify the anisotropic cell response in 3D hydrogels with stiffness-degradation spatial patterns. Our results show that patterning of stiffness and degradability allows to control cell anisotropic response in 3D and can be quantified by image-based strategies. This allows a deeper understanding of cell-matrix interactions in a multicomponent material.

bioengineering↗

bioRxiv2023

From breast cancer cell homing to the onset of early bone metastasis: dynamic bone (re)modeling as a driver of osteolytic disease

Breast cancer often metastasizes to bone causing osteolytic lesions. Structural and biophysical changes are rarely studied, yet are hypothesized to influence metastatic progression. Here, we developed a mouse model of early bone metastasis and multimodal 3D imaging to quantify cancer cell homing, dynamic bone (re)modeling and onset of bone metastasis. Using 3D light sheet fluorescence microscopy, we show eGFP+ cancer cells and small clusters in 3D (intact) bones. We detect early bone lesions using time-lapse in vivo microCT and reveal altered bone (re)modeling in absence of detectable lesions. With a new microCT image analysis tool, we detect and track the growth of early bone lesions over time. We show that cancer cells home in all bone compartments, while osteolytic lesions are only detected in the metaphysis, a region of high (re)modeling. Our study provides novel insights of dynamic bone (re)modeling as a driver during the early phase of metastasis.

bioengineering↗

bioRxiv2020

HIF-stabilization prevents delayed fracture healing

The initial phase of fracture healing decides on success of bone regeneration and is characterized by an inflammatory milieu and low oxygen tension (hypoxia). Negative interference with or prolongation of this fine-tuned initiation phase will ultimately lead to a delayed or incomplete healing such as non-unions which then requires an effective and gentle therapeutic intervention. Common reasons include a dysregulated immune response, immunosuppression or a failure in cellular adaptation to the inflammatory hypoxic milieu of the fracture gap and a reduction in vascularizing capacity by environmental noxious agents (e.g. rheumatoid arthritis, smoking). The hypoxia-inducible factor (HIF)-1α is responsible for the cellular adaptation to hypoxia, activating angiogenesis and supporting cell attraction and migration to the fracture gap. Here, we hypothesized that stabilizing HIF-1α could be a cost-effective and low-risk prevention strategy of fracture healing disorders. Therefore, we combined a well-known HIF-stabilizer – deferoxamine (DFO) – and a less known HIF-enhancer – macrophage migration inhibitory factor (MIF) – to synergistically induce improved fracture healing. Stabilization of HIF-1α enhanced calcification and osteogenic differentiation of MSCs in vitro. In vivo, the application of DFO with or without MIF during the initial healing phase accelerated callus mineralization and vessel formation in a clinically relevant mouse-osteotomy-model in a compromised healing setting. Our findings provide support for a promising preventive strategy towards bone healing disorders in patients with a higher risk due to e.g. delayed neovascularization by accelerating fracture healing using DFO and MIF to stabilize HIF-1α.Competing Interest StatementThe authors have declared no competing interest.View Full Text

bioengineering↗

bioRxiv2020

In vivo validation of spray-dried mesoporous bioactive glass microspheres acting as prolonged local release systems for BMP-2 to induce bone regeneration

Despite years of diligent research in fracture healing, an unmet clinical need for safe and effective pharmacological treatments to improve bone regeneration persists with 10 - 20 % of fracture cases exhibiting impaired healing. Bone morphogenetic protein-2 (BMP-2) is a known key mediator of physiological bone regeneration and is clinically approved for selected musculoskeletal interventions. Yet, broad usage of this growth factor is impeded due to side effects that are majorly evoked by high dosages and burst release kinetics. In this study, mesoporous bioactive glass microspheres (MBGs) produced by an aerosol assisted spray-drying, scalable process were found to be biocompatible and to induce a pro-osteogenic response on human MSCs in vitro. Loading of the MBGs with BMP-2 resulted in prolonged, low-dose BMP-2 release without affecting the material features. In a pre-clinical rodent model, BMP-2 loaded MBGs significantly enhanced bone formation and influenced the microarchitecture of newly formed bone. The MBG carriers alone performed equal to the untreated (empty) control in most parameters tested, while additionally exerting mild pro-angiogenic effects. Using MBGs as a biocompatible, pro-regenerative carrier for local and sustained low dose BMP-2 release could limit side effects, thus enabling a safer usage of BMP-2 as a potent pro-osteogenic growth factor.

cell biology↗

bioRxiv2018

Placental-expanded, mesenchymal cells improve muscle function following hip arthroplasty

BackgroundNo regenerative approach has thus far been shown to be effective in skeletal muscle injuries, despite high frequency and associated functional deficits. We sought to address surgical trauma related muscle injuries using local intraoperative application of allogeneic placenta-derived, mesenchymal-like adherent cells (PLX-PAD), using hip arthroplasty as a standardized injury model, because of the high regenerative and immunomodulatory potency of this cell type.\n\nMethodsOur pilot phase I/IIa study was prospective, randomized, double blind and placebo-controlled. Twenty patients undergoing hip arthroplasty via a direct lateral approach were injected with 3.0x108 or 1.5x108 PLX-PAD or a placebo into the gluteus medius muscle.\n\nResultsWe did not observe any relevant PLX-PAD-related adverse events at the 2-year follow-up. Improved gluteus medius strength was noted as early as week 6 in the treatment-groups. Surprisingly, until week 26 the low-dose outperformed the high-dose group and reached significantly improved strength compared to placebo, mirrored by an increase in muscle volume. Histology indicated accelerated healing after cell therapy. Biomarker studies revealed that low-dose treatment reduced the surgery-related immunological stress reaction more than high-dose. Signs of late-onset immune reactivity after high-dose treatment corresponded to reduced functional improvement.\n\nConclusionAllogeneic PLX-PAD therapy improved strength and volume of injured skeletal muscle with a reasonable safety profile. Outcomes could be positively correlated with the modulation of early postoperative stress-related immunological reactions.\n\nTrial RegistrationClinicalTrials.gov (number NCT01525667) and EudraCT (number 2011-003934-16)\n\nFundingThe study was funded by the Sponsor, Pluristem Therapeutics, the Israeli innovation authority and the German Federal Ministry of Education and Research.\n\nConflict of interestT. Winkler, C. Perka and G.N. Duda are members of a clinical advisory board of Pluristem Ltd for future indications. T. Winkler, C. Perka, G.N. Duda, P. von Roth filed a patent together with Pluristem Ltd. E. Lukasiewicz Hagai, R. Ofir, L. Pinzur and E. Eyal are current or former employees of Pluristem Ltd. T. Winkler, P. Reinke and H.-D. Volk received in the past consulting fees from Pluristem Ltd. but not for this project.

clinical trials↗